Do Kids Get COVID? Pediatrician-Reviewed Facts (2026)

By David Thompson · August 26, 2024

Why This Question Matters More Than Ever

Yes, do kids get COVID — and they absolutely do. But the reality is far more nuanced than headlines suggest: while children are just as likely as adults to become infected with SARS-CoV-2, their clinical outcomes differ profoundly due to immune development, viral kinetics, and evolving variants. Since late 2023, pediatric hospitalizations have risen 40% year-over-year during seasonal surges (CDC, April 2024), yet over 95% of cases remain mild or asymptomatic. What parents truly need isn’t alarm — it’s clarity: Which kids face higher risk? When does a sniffle warrant testing? How well do updated vaccines protect against XBB.1.5 or JN.1? And crucially — how do you balance protection with normal childhood development? This guide cuts through misinformation using data from the American Academy of Pediatrics (AAP), CDC surveillance reports, and insights from pediatric infectious disease specialists who’ve treated over 12,000 pediatric cases since 2020.

How COVID Affects Kids: Age Is Everything

Children aren’t just ‘small adults’ — their immune systems respond to SARS-CoV-2 in developmentally distinct ways. Infants under 6 months have immature adaptive immunity and rely heavily on maternal antibodies; toddlers (1–4 years) mount robust innate responses but lack memory T-cell breadth; school-age children (5–11) show strong antibody persistence post-infection; and adolescents (12–17) mirror adult immune kinetics but with lower ACE2 receptor density in nasal epithelium — potentially slowing initial viral entry. Dr. Lena Chen, pediatric infectious disease specialist at Children’s Hospital Los Angeles, explains: “We see a U-shaped risk curve: highest hospitalization rates in infants <6 months and teens >15, with a dip in middle childhood — not because they’re invulnerable, but because their interferon response is exceptionally rapid.”

This biological reality explains why symptoms diverge so sharply by age:

Infants & toddlers: Fever, poor feeding, lethargy, respiratory distress (grunting, nasal flaring), and sometimes gastrointestinal upset — often the only signs before oxygen saturation drops.
School-age children: Mild sore throat, runny nose, headache, and fatigue — frequently mistaken for common colds. Loss of taste/smell occurs in ~35% (per JAMA Pediatrics 2023 cohort study).
Teens: Higher rates of prolonged fatigue (>4 weeks), orthostatic intolerance, and post-exertional malaise — overlapping significantly with Long COVID presentations seen in young adults.

A critical nuance: While severe acute disease remains rare in healthy children, multisystem inflammatory syndrome in children (MIS-C) — a delayed, hyperinflammatory response occurring 2–6 weeks post-infection — still affects ~1 in 3,200 pediatric COVID cases (CDC 2024). It’s treatable when caught early, but requires urgent recognition: persistent fever + rash + conjunctivitis + abdominal pain + low blood pressure. Parents should know this triad — and call their pediatrician immediately if it emerges.

Vaccination: What the Latest Data Says (and What It Doesn’t)

The 2023–2024 monovalent XBB.1.5 vaccines reduced symptomatic infection risk by 52% in children aged 6 months–4 years and 68% in 5–11 year-olds (NEJM, March 2024), but protection wanes significantly after 4 months. For adolescents, efficacy against hospitalization held steady at 86% through 6 months — reinforcing that the primary benefit is preventing severe outcomes, not blocking all infection.

Crucially, vaccination status interacts powerfully with prior infection history. Children with both prior infection and vaccination show 92% protection against hospitalization for 8+ months — the strongest durable immunity observed (Kaiser Permanente study, Jan 2024). Yet only 38% of U.S. children under 5 are fully vaccinated, and 47% of 5–11 year-olds have received even one dose of the updated vaccine. Barriers cited most often by parents in AAP focus groups? Misconceptions about myocarditis risk (which remains <1 per 100,000 doses in males 12–17, and resolves fully in >95% of cases) and uncertainty about optimal timing relative to recent infection.

Here’s what pediatricians recommend:

Wait 3 months after a confirmed COVID infection before vaccinating — allowing natural immunity to mature alongside vaccine-induced B-cell memory.
For immunocompromised children (e.g., those on biologics, chemotherapy, or with primary immunodeficiency), consult your specialist: many require 3 primary doses plus boosters every 6 months.
Don’t delay kindergarten or school-entry vaccines — co-administering COVID shots with DTaP, MMR, or flu vaccine is safe and improves adherence (per AAP policy statement, Sept 2023).

When to Test, Treat, and Seek Care: A Practical Decision Tree

With rapid antigen tests widely available, knowing when to use them — and what to do with the result — reduces unnecessary ER visits and missed red flags. The following table synthesizes AAP clinical guidance and real-world triage protocols used in 12 major children’s hospitals:

Scenario	Action	Rationale & Evidence
Fever + cough + fatigue in child >3 months	Test with rapid antigen; if negative but symptoms persist >24h, repeat test or PCR	Rapid tests miss ~25% of early infections in kids (Pediatrics, 2023); sensitivity improves to >95% after day 2 of symptoms.
Infant <3 months with fever ≥100.4°F (38°C)	Seek urgent medical evaluation regardless of test result	Febrile infants require sepsis workup — COVID can suppress white counts, masking bacterial co-infection.
Known exposure + no symptoms	Test on day 3–5 post-exposure; isolate if positive	Incubation median is 3.2 days in children (Nature Communications, 2024); pre-symptomatic transmission peaks 1 day before onset.
Persistent fatigue >2 weeks + brain fog + dizziness on standing	Consult pediatrician; consider autonomic testing (tilt-table) and cardiology referral	Orthostatic intolerance is the most common Long COVID presentation in teens (63% of 12–17yo in NIH RECOVER study).
MIS-C suspicion (fever + rash + abdominal pain)	Go to ER immediately — do not wait for test results	Median time from symptom onset to ICU admission is 2.1 days; mortality drops from 2.1% to 0.3% with treatment within 24h.

Treatment options remain limited but impactful. Paxlovid is FDA-authorized for children ≥12 years weighing ≥40 kg and shows 89% reduction in hospitalization when started within 5 days (EPIC-HR trial extension). For younger kids, supportive care — hydration, antipyretics, rest — remains standard. Notably, ibuprofen is safe and often preferred over acetaminophen for persistent fever in children >6 months (per AAP 2023 pharmacotherapy update), debunking the outdated myth that NSAIDs worsen COVID outcomes.

Protecting Your Child Without Isolation: Realistic, Sustainable Strategies

Parents consistently tell us they’re exhausted by binary choices: ‘full normalcy’ versus ‘constant masking.’ Evidence supports a third path: layered, risk-proportionate mitigation calibrated to your child’s health status and community transmission level. Dr. Amara Patel, a pediatric pulmonologist and co-author of the AAP’s 2024 Respiratory Virus Guidance, advises: “Think of protection like sunscreen — you wouldn’t skip SPF 30 because clouds are out. Similarly, high-quality masks in crowded indoor settings during high community transmission are reasonable for high-risk kids, just as hand hygiene is non-negotiable for daycare attendees.”

Effective strategies include:

Ventilation upgrades: Portable HEPA filters in classrooms and bedrooms reduce airborne viral load by up to 85% (Harvard T.H. Chan School of Public Health, 2023). Even opening two windows diagonally across a room creates cross-ventilation that halves particle concentration in under 10 minutes.
Targeted masking: For children with asthma, cystic fibrosis, or cancer, wearing an N95 or KN95 during air travel, concerts, or ER visits cuts infection risk by 73% (JAMA Internal Medicine, Feb 2024).
Nasal saline irrigation: Daily hypertonic saline rinses (using FDA-cleared devices like NeilMed® Sinus Rinse) reduced upper respiratory infection frequency by 32% in a 6-month RCT of 217 schoolchildren (Pediatric Allergy and Immunology, 2023).
Probiotic synergy: Lactobacillus rhamnosus GG (10 billion CFU daily) shortened COVID symptom duration by 2.1 days in children 1–12 years (European Journal of Clinical Nutrition, 2024) — likely via gut-immune axis modulation.

Importantly, social-emotional health must be part of the equation. A longitudinal study tracking 1,800 children found that those with >6 months of school absenteeism during 2020–2022 had 2.4× higher odds of anxiety diagnosis by age 10 (JAMA Pediatrics, May 2024). Protection isn’t just physical — it’s ensuring your child feels safe, connected, and capable.

Frequently Asked Questions

Can newborns get COVID from their mother during delivery?

No — vertical transmission (mother-to-fetus during pregnancy or delivery) is extremely rare (<0.1% of births where mother tests positive near term). The greater risk is postnatal exposure from caregivers. CDC recommends mothers with active COVID wear a mask and practice hand hygiene while breastfeeding; breast milk contains protective antibodies and is strongly encouraged. A 2024 Lancet study of 1,200 mother-infant dyads confirmed zero cases of transmission via breast milk.

Does having COVID once make my child immune to future infection?

No — reinfection is common, especially with new variants. Children who had Omicron BA.1 have only ~25% protection against BA.5, and ~15% against XBB.1.5 (Cell, 2023). However, each infection broadens immune memory: kids with 2+ prior infections show stronger cross-reactive T-cell responses to novel variants. Think of immunity as layers of defense — not a locked door.

Are cloth masks effective for kids?

Not reliably. Most cloth masks filter <20% of 0.3-micron particles — the size of SARS-CoV-2 virions. For children under 8, well-fitted surgical masks offer better protection; for older kids, KN95s or KF94s are ideal. Fit matters more than material: a poorly fitting N95 is less protective than a well-fitted surgical mask. Practice mask-wearing during calm moments (e.g., reading together) to build comfort.

Should I keep my child home from school for mild cold-like symptoms?

Yes — but with nuance. The AAP’s 2024 ‘Respiratory Virus Policy’ states: “Any child with fever, cough, shortness of breath, or loss of taste/smell should stay home until fever-free for 24h without meds AND symptoms improve.” For runny nose or sore throat alone, testing is advised — but attendance may resume pending negative results, as these symptoms overlap with 200+ non-COVID viruses.

Is Long COVID real in children — and how is it diagnosed?

Yes — and it’s underrecognized. The NIH RECOVER Initiative defines pediatric Long COVID as symptoms persisting >3 months post-infection that cannot be explained by another diagnosis. Common presentations include fatigue, cognitive dysfunction (“brain fog”), headache, and autonomic issues (POTS-like symptoms). Diagnosis is clinical — no single test exists — but pediatricians use validated tools like the PedsQL Fatigue Scale and tilt-table testing. Early referral to a multidisciplinary Long COVID clinic improves outcomes significantly.

Common Myths

Myth 1: “Kids don’t spread COVID — they’re just passive victims.”
False. While children transmit less efficiently than adults per contact, their high social mixing (school, sports, playdates) makes them significant drivers of community spread — especially unvaccinated children aged 5–11, who accounted for 31% of U.S. pediatric cases in Q1 2024 (CDC MMWR). Viral loads in infected kids match adults’, meaning they exhale comparable amounts of virus.

Myth 2: “If my child has asthma, they’ll definitely get very sick from COVID.”
Outdated. Pre-Omicron data suggested higher risk, but post-2022 studies show well-controlled asthma confers no increased risk of hospitalization. In fact, inhaled corticosteroids may reduce severe outcomes by dampening airway inflammation (Lancet Respiratory Medicine, 2023). Uncontrolled asthma remains a concern — highlighting the importance of consistent controller medication use.

Your Next Step Starts With One Action

You now know that do kids get COVID — yes, frequently — but also that severity, protection, and recovery are highly individualized, evidence-guided, and within your sphere of influence. Don’t wait for the next wave to decide on vaccination timing, review your school’s ventilation plan, or practice using rapid tests with your child. Start today: Download the free AAP Pediatric COVID Symptom Tracker (link) — a printable, clinician-designed tool to log fever, oxygen levels, and red-flag symptoms — and schedule a 15-minute ‘immunity check-in’ with your pediatrician to discuss your child’s unique risk profile. Because protecting your child isn’t about perfection — it’s about preparedness, partnership, and peace of mind grounded in science.